Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program

Akihito Tanaka, Daijo Inaguma, Yu Watanabe, Minako Murata, Hibiki Shinjo, Kiyomi Koike, Yasuhiro Otsuka, Asami Takeda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients with malignancy have a poorer prognosis than others do, which must be taken into consideration when treating them for chronic kidney disease (CKD). However, there are few studies investigating their prognosis. This was an observational study of 515 (394 men and 121 women) stable non-dialysis patients with CKD who attended a CKD educational program. Mean age was 68.8 ± 13.0 years. Median follow-up was 968.5 days. Mean creatinine was 3.4 ± 1.6 mg/dL. Of these, 63 had malignancy and 452 did not; 20.6% of the former and 11.9% of the latter group died by the end of the study period (P = 0.0548). Malignancy was not associated with all-cause mortality (HR: 1.3475, 95% CI: 0.7202–2.5214, P = 0.3507) but with malignancy-associated mortality (HR: 3.9477, 95% CI: 1.6348–9.5331, P = 0.0023). Renal replacement therapy was not associated with mortality. Since malignancy greatly affects the prognosis, it must be taken into consideration when treating these patients.

Original languageEnglish
Pages (from-to)49-57
Number of pages9
JournalTherapeutic Apheresis and Dialysis
Volume22
Issue number1
DOIs
Publication statusPublished - 01-02-2018

Fingerprint

Chronic Renal Insufficiency
Mortality
Neoplasms
Renal Replacement Therapy
Observational Studies
Creatinine

All Science Journal Classification (ASJC) codes

  • Hematology
  • Nephrology

Cite this

Tanaka, Akihito ; Inaguma, Daijo ; Watanabe, Yu ; Murata, Minako ; Shinjo, Hibiki ; Koike, Kiyomi ; Otsuka, Yasuhiro ; Takeda, Asami. / Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program. In: Therapeutic Apheresis and Dialysis. 2018 ; Vol. 22, No. 1. pp. 49-57.
@article{ee178b5c7b884ff5b01bb072efd453cb,
title = "Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program",
abstract = "Patients with malignancy have a poorer prognosis than others do, which must be taken into consideration when treating them for chronic kidney disease (CKD). However, there are few studies investigating their prognosis. This was an observational study of 515 (394 men and 121 women) stable non-dialysis patients with CKD who attended a CKD educational program. Mean age was 68.8 ± 13.0 years. Median follow-up was 968.5 days. Mean creatinine was 3.4 ± 1.6 mg/dL. Of these, 63 had malignancy and 452 did not; 20.6{\%} of the former and 11.9{\%} of the latter group died by the end of the study period (P = 0.0548). Malignancy was not associated with all-cause mortality (HR: 1.3475, 95{\%} CI: 0.7202–2.5214, P = 0.3507) but with malignancy-associated mortality (HR: 3.9477, 95{\%} CI: 1.6348–9.5331, P = 0.0023). Renal replacement therapy was not associated with mortality. Since malignancy greatly affects the prognosis, it must be taken into consideration when treating these patients.",
author = "Akihito Tanaka and Daijo Inaguma and Yu Watanabe and Minako Murata and Hibiki Shinjo and Kiyomi Koike and Yasuhiro Otsuka and Asami Takeda",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/1744-9987.12598",
language = "English",
volume = "22",
pages = "49--57",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "1",

}

Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program. / Tanaka, Akihito; Inaguma, Daijo; Watanabe, Yu; Murata, Minako; Shinjo, Hibiki; Koike, Kiyomi; Otsuka, Yasuhiro; Takeda, Asami.

In: Therapeutic Apheresis and Dialysis, Vol. 22, No. 1, 01.02.2018, p. 49-57.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Relationship Between Mortality and Cancer-Bearing Status in Patients With Chronic Kidney Disease Who Attended an Educational Program

AU - Tanaka, Akihito

AU - Inaguma, Daijo

AU - Watanabe, Yu

AU - Murata, Minako

AU - Shinjo, Hibiki

AU - Koike, Kiyomi

AU - Otsuka, Yasuhiro

AU - Takeda, Asami

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Patients with malignancy have a poorer prognosis than others do, which must be taken into consideration when treating them for chronic kidney disease (CKD). However, there are few studies investigating their prognosis. This was an observational study of 515 (394 men and 121 women) stable non-dialysis patients with CKD who attended a CKD educational program. Mean age was 68.8 ± 13.0 years. Median follow-up was 968.5 days. Mean creatinine was 3.4 ± 1.6 mg/dL. Of these, 63 had malignancy and 452 did not; 20.6% of the former and 11.9% of the latter group died by the end of the study period (P = 0.0548). Malignancy was not associated with all-cause mortality (HR: 1.3475, 95% CI: 0.7202–2.5214, P = 0.3507) but with malignancy-associated mortality (HR: 3.9477, 95% CI: 1.6348–9.5331, P = 0.0023). Renal replacement therapy was not associated with mortality. Since malignancy greatly affects the prognosis, it must be taken into consideration when treating these patients.

AB - Patients with malignancy have a poorer prognosis than others do, which must be taken into consideration when treating them for chronic kidney disease (CKD). However, there are few studies investigating their prognosis. This was an observational study of 515 (394 men and 121 women) stable non-dialysis patients with CKD who attended a CKD educational program. Mean age was 68.8 ± 13.0 years. Median follow-up was 968.5 days. Mean creatinine was 3.4 ± 1.6 mg/dL. Of these, 63 had malignancy and 452 did not; 20.6% of the former and 11.9% of the latter group died by the end of the study period (P = 0.0548). Malignancy was not associated with all-cause mortality (HR: 1.3475, 95% CI: 0.7202–2.5214, P = 0.3507) but with malignancy-associated mortality (HR: 3.9477, 95% CI: 1.6348–9.5331, P = 0.0023). Renal replacement therapy was not associated with mortality. Since malignancy greatly affects the prognosis, it must be taken into consideration when treating these patients.

UR - http://www.scopus.com/inward/record.url?scp=85041666519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041666519&partnerID=8YFLogxK

U2 - 10.1111/1744-9987.12598

DO - 10.1111/1744-9987.12598

M3 - Article

VL - 22

SP - 49

EP - 57

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 1

ER -